Currently, there are 29.13M common shares owned by the public and among those 27.16M shares have been available to trade.
The company’s stock has a 5-day price change of -30.98% and 19.92% over the past three months. RMTI shares are trading 49.74% year to date (YTD), with the 12-month market performance up to 53.80% higher. It has a 12-month low price of $1.16 and touched a high of $5.15 over the same period. RMTI has an average intraday trading volume of 604.47K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -25.03%, -23.87%, and 25.11% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Rockwell Medical Inc (NASDAQ: RMTI) shares accounts for 20.70% of the company’s 29.13M shares outstanding.
It has a market capitalization of $87.82M and a beta (3y monthly) value of 1.56. The earnings-per-share (ttm) stands at -$0.05. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.93% over the week and 7.74% over the month.
Earnings per share for the fiscal year are expected to increase by 91.67%, and 333.33% over the next financial year. EPS should shrink at an annualized rate of 38.00% over the next five years, compared to 44.20% over the past 5-year period.
Looking at the support for the RMTI, a number of firms have released research notes about the stock. Piper Jaffray stated their Overweight rating for the stock in a research note on June 24, 2019, with the firm’s price target at $10. H.C. Wainwright coverage for the Rockwell Medical Inc (RMTI) stock in a research note released on May 13, 2019 offered a Buy rating with a price target of $11. Morgan Stanley on their part issued Underweight rating on August 13, 2015.
